 FORT LEE, N.J., Oct. 03, 2022 GLOBE NEWSWIRE -- Nuvectis Pharma, Inc. Nuvectis, Company, a biopharmaceutical company focused on the development of innovative precision medicines for the treatment of serious conditions of unmet medical need in oncology, today announced that the Companys management team will participate at the Roth Inaugural Healthcare Opportunities Conference. 